RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 77 filers reported holding RECRO PHARMA INC in Q3 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,000 | 0.0% | 1,686 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | +25.0% | 1,686 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -50.0% | 1,686 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | -42.9% | 1,686 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $14,000 | -54.8% | 1,686 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $31,000 | +138.5% | 1,686 | +41.0% | 0.00% | 0.0% |
| Q3 2019 | $13,000 | +8.3% | 1,196 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,000 | +71.4% | 1,196 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | -12.5% | 1,196 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -11.1% | 1,196 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | +50.0% | 1,196 | 0.0% | 0.00% | – |
| Q2 2018 | $6,000 | -53.8% | 1,196 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $13,000 | +18.2% | 1,196 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $11,000 | +22.2% | 1,196 | 0.0% | 0.00% | – |
| Q3 2017 | $9,000 | +12.5% | 1,196 | 0.0% | 0.00% | – |
| Q2 2017 | $8,000 | – | 1,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |